World Journal of Gastroenterology
Cure8 research brief
Why This Matters
This study reports preclinical evidence that an herbal extract (EGST) reduced inflammation and epithelial cell ferroptosis in a mouse model of ulcerative colitis and in cell experiments, implicating the PPARγ/GPX4 pathway and bile-acid changes. That suggests a potential new mechanism to target epithelial injury in IBD.
Who Should Pay Attention
Researchers studying IBD mechanisms or new therapeutics, clinicians interested in emerging preclinical findings, and patients curious about experimental herbal extracts (for awareness, not as treatment advice).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper combines mouse experiments, Caco-2 cell assays, network pharmacology, molecular docking/simulations, and targeted bile-acid metabolomics. In mice, EGST improved colon length and histology and altered inflammatory cytokines. In vitro, EGST countered erastin-induced markers of ferroptosis and preserved mitochondrial structure.
Computational work identified β-sitosterol as a potential PPARγ binder, and molecular data showed increased PPARγ and GPX4 expression similar to a known agonist. This is a mechanistic, preclinical report that suggests a possible pathway (PPARγ→GPX4) and bile-acid changes (THDCA) by which EGST may protect the epithelium.
It does not provide clinical safety or efficacy data in humans, dosing guidance, or regulatory status for EGST as a treatment.
Keep In Mind
Findings come from DSS-colitis mice, Caco-2 cell assays, and computational analyses; this is mechanistic preclinical research and does not establish safety or effectiveness in humans.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationWorld Journal of Gastroenterology
PublisherBaishideng Publishing Group Inc.
AuthorsZi-Yun Zhuo, Xiao-Ya Guo, Xiao-Ming Liu +4 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 28, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Mechanism and Active ingredients of Gancao Qinlian Granules in ameliorating ulcerative colitis:integrated in vivo, in vitro, network pharmacology and untargeted metabolomics investigation.
The paper presents integrated preclinical evidence that a multi-herb formula (GQG) can reduce inflammation and alter gut microbiota and metabolites in a mouse model of ulcerative colitis, highlighting possible mechanisms...
Network Pharmacology-Metabolomics Integration Reveals the Multiple Targets and Mechanisms of Total Glucosides of Paeony Against Ulcerative Colitis.
Researchers used laboratory mouse and cell models to show that total glucosides of paeony (TGP) may reduce inflammation linked to ulcerative colitis and identified molecular pathways (COX‑2/arachidonic acid, NF‑κB, MAPK,...
Enhancing the efficacy of ulcerative colitis treatment by inhibiting LCN2-mediated pyroptosis through traditional processing techniques: With the rhizome of Atractylodes macrocephala Koidz. as an example.
This study suggests a traditional processing method may change a common herbal used for UC so it works better in mouse and cell models, and it proposes a specific molecular pathway (LCN2‑mediated pyroptosis) that could...